These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8110811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
    Bernstrom K, Malcolm K, McGee J, Maclouf J, Levy-Toledano S, Falck JR, Fitzpatrick FA.
    Mol Pharmacol; 1991 Feb; 39(2):114-9. PubMed ID: 1847490
    [Abstract] [Full Text] [Related]

  • 3. The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100.
    Reynaud D, Clark D, Qiao N, Rand ML, Pace-Asciak CR.
    Thromb Res; 2003 Feb; 112(4):245-8. PubMed ID: 14987919
    [No Abstract] [Full Text] [Related]

  • 4. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.
    Reynaud D, Hinek A, Pace-Asciak CR.
    FEBS Lett; 2002 Mar 27; 515(1-3):58-60. PubMed ID: 11943194
    [Abstract] [Full Text] [Related]

  • 5. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
    Nyby MD, Sasaki M, Ideguchi Y, Wynne HE, Hori MT, Berger ME, Golub MS, Brickman AS, Tuck ML.
    J Pharmacol Exp Ther; 1996 Aug 27; 278(2):503-9. PubMed ID: 8768697
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038
    [Abstract] [Full Text] [Related]

  • 8. Initiation of RVD response in human platelets: mechanical-biochemical transduction involves pertussis-toxin-sensitive G protein and phospholipase A2.
    Margalit A, Livne AA, Funder J, Granot Y.
    J Membr Biol; 1993 Dec 19; 136(3):303-11. PubMed ID: 8114080
    [Abstract] [Full Text] [Related]

  • 9. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC, Jiang X.
    Thromb Haemost; 2010 Aug 19; 104(2):302-10. PubMed ID: 20589316
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T, Itaya S, Wada H, Ishizawa M, Kimura M, Kajita K, Kanoh Y, Miura A, Muto N, Yasuda K.
    Diabetes; 1998 Sep 19; 47(9):1494-500. PubMed ID: 9726240
    [Abstract] [Full Text] [Related]

  • 12. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903
    [Abstract] [Full Text] [Related]

  • 13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 14. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC, Huang SW, Hwang TL, Kuo SC, Lee FY, Teng CM.
    Br J Pharmacol; 2000 Jul 15; 130(6):1289-96. PubMed ID: 10903968
    [Abstract] [Full Text] [Related]

  • 15. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M.
    Acta Pol Pharm; 2009 Jul 15; 66(3):235-42. PubMed ID: 19645323
    [Abstract] [Full Text] [Related]

  • 16. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation.
    Chiang TM.
    Biochim Biophys Acta; 1994 Oct 20; 1224(1):147-55. PubMed ID: 7948037
    [Abstract] [Full Text] [Related]

  • 17. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D, Gear A.
    Thromb Res; 2007 Oct 20; 120(6):885-92. PubMed ID: 17306868
    [Abstract] [Full Text] [Related]

  • 18. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep 20; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 19. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun 20; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 20. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T, Kawasaki T, Taniguchi M, Moritani Y, Hayashi K, Saito T, Takasaki J, Uchida W, Miyata K.
    Br J Pharmacol; 2006 May 20; 148(1):61-9. PubMed ID: 16520742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.